Evidence map›Paper›PMID 31222863›Full record

ArticleCancer science2019

Hypoxia decreases macrophage glycolysis and M1 percentage by targeting microRNA-30c and mTOR in human gastric cancer.

Yun Zhihua, Tan Yulin, Wang Yibo, Ding Wei, Chu Yin, Xu Jiahao, Jiang Runqiu, Xu Xuezhong

Open access · goldAbstract read
In one paragraph

Article in Cancer science, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed, 2 pooled it
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 2 syntheses or guidelines pooled it, 64 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. International journal of molecular medicine · 2026
    Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. mTOR Signaling in Macrophages: All Depends on the Context.International journal of molecular sciences · 2025
    Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Energy metabolism: a new target for gastric cancer treatment.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2024
    Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Yun ZhihuaDepartment of Laboratory Medicine, People's Hospital of Wujin, Changzhou, China.
Tan YulinDepartment of Surgery, People's Hospital of Wujin, Changzhou, China.
Wang YiboDepartment of Surgery, People's Hospital of Wujin, Changzhou, China.
Ding WeiDepartment of Surgery, People's Hospital of Wujin, Changzhou, China.
Chu YinDepartment of Laboratory Medicine, People's Hospital of Wujin, Changzhou, China.
Xu JiahaoDepartment of Laboratory Medicine, People's Hospital of Wujin, Changzhou, China.
Jiang RunqiuDepartment of Hepatobiliary Surgery, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China.ORCID https://orcid.org/0000-0002-6995-9557
Xu XuezhongDepartment of Surgery, People's Hospital of Wujin, Changzhou, China.
Nanjing Drum Tower Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Macrophages are essential inflammatory cells which regulate the features of immune reactions within tumors. Many studies have reported their regulatory roles in immunity through cytokines and cell signaling. However, relatively few studies have focused on their metabolic features and mechanisms. We aimed to determine the signaling pathway regulating cell metabolism and the mechanism related to the regulation of human tumor-associated macrophages (TAMs) in gastric cancer (GC). Tumor-infiltrated macrophages were isolated from human GC tissues using magnetic beads, gene transcription was determined by real-time PCR, protein expression was monitored using western blots, metabolites were determined using HPLC, and transcriptional regulation was analyzed by the luciferase-based reporter gene system. A significant decrease in microRNA (miR)-30c and an increase in regulated in development and DNA damage responses 1 (REDD1) were detected in human GC TAMs, the transcription of miR-30c was negatively correlated with REDD1. MicroRNA-30c expression was suppressed by hypoxia-inducible factor-1α activation and related to decreased mTOR activity as well as glycolysis in human GC TAMs. Hypoxia-regulated miR-30c downregulated REDD-1 expression by targeting its 3'UTR. Overexpression of miR-30c or restored mTOR activity in macrophages with miR-30c

Indexed as

3' Untranslated RegionsCell DifferentiationCell LineCell ProliferationDown-RegulationFemaleGene Expression Regulation, NeoplasticGlycolysisHumansHypoxiaHypoxia-Inducible Factor 1, alpha SubunitMacrophagesMaleMicroRNAsMiddle AgedSignal Transduction3' Untranslated RegionsHypoxia-Inducible Factor 1, alpha SubunitMicroRNAsMIRN30b microRNA, humanMTOR protein, humanTOR Serine-Threonine KinasesTranscription Factorsgastric cancermacrophagemiR-30cmTORREDD-1

Identifiers

PMID31222863
PMCPMC6676118
OpenAlexW2950223061

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.